On March 6, 2025, a Decree providing guidelines about the technical collaboration between the Mexican Institute of Industrial Property (IMPI) and the Federal Commission for Protection against Health ...

This spring, the Supreme Court of Canada (SCC) will consider the scope of patentable subject-matter as it relates to “methods ...

Expenses incurred by a generic drug manufacturer in defending Hatch-Waxman patent litigation are deductible as ordinary and necessary business expenses, the U.S. Court of Appeals for the Federal ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Nathan Mammen and Cole Tipton of Snell & Wilmer LLP address the question as to how AI could affect or even upend determining ...

In 2021, the 30.7 million beneficiaries accounted for over $2 billion in payments for the 101 generic drugs. Under the ...

The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy ...

The Patent Term Extension (PTE) provisions of 35 U.S.C. § 156 compensate pharmaceutical patent owners for time they are not ...

Prometric, a global leader in professional and educational assessment, has achieved a major industry milestone by securing the first U.S. patent for AI-powered item generation technology. The patent—U ...

Sunshine Biopharma (SBFM) announced that is has signed a strategic agreement granting it the rights to market two new generic antibiotics in ...

This article is authored by Dr YK Gupta, president, AIIMS, Jammu and Ankush Kapoor, founder & CEO, Pharma NXT Biotech.

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...